| Primary |
| Asthma |
54.4% |
| Drug Use For Unknown Indication |
17.6% |
| Product Used For Unknown Indication |
4.4% |
| Rhabdomyosarcoma |
4.4% |
| Cough |
3.7% |
| Tracheitis |
2.2% |
| Arthritis |
1.5% |
| Bronchitis |
1.5% |
| Fluid Retention |
1.5% |
| Laryngitis Viral |
1.5% |
| Wheezing |
1.5% |
| Anxiety |
0.7% |
| Blood Uric Acid |
0.7% |
| Drug Dependence |
0.7% |
| Insomnia |
0.7% |
| Pain |
0.7% |
| Rhinitis Allergic |
0.7% |
| Sarcoma |
0.7% |
| Tremor |
0.7% |
|
| Pharmaceutical Product Complaint |
13.2% |
| Asthma |
7.9% |
| Pneumonia |
7.9% |
| Skin Striae |
7.9% |
| Wheezing |
7.9% |
| Loss Of Consciousness |
5.3% |
| Overdose |
5.3% |
| Pharyngeal Oedema |
5.3% |
| Rash |
5.3% |
| Viral Upper Respiratory Tract Infection |
5.3% |
| Vocal Cord Paralysis |
5.3% |
| Aggression |
2.6% |
| Coma |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Foetal Exposure During Pregnancy |
2.6% |
| Lactic Acidosis |
2.6% |
| Laryngeal Cancer |
2.6% |
| Live Birth |
2.6% |
| Lung Disorder |
2.6% |
| Mucosal Inflammation |
2.6% |
|
| Secondary |
| Asthma |
29.8% |
| Product Used For Unknown Indication |
23.4% |
| Rhabdomyosarcoma |
11.2% |
| Emphysema |
6.4% |
| Asthmatic Crisis |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Drug Dependence |
3.7% |
| Aortic Valve Incompetence |
2.1% |
| Bronchopneumopathy |
2.1% |
| Insomnia |
1.6% |
| Lobar Pneumonia |
1.6% |
| Pain |
1.6% |
| Respiratory Failure |
1.6% |
| Tremor |
1.6% |
| Cough |
1.1% |
| Premature Menopause |
1.1% |
| Prophylaxis |
1.1% |
| Arrhythmia |
0.5% |
| Atrial Fibrillation |
0.5% |
| Breast Cancer |
0.5% |
|
| Foetal Exposure During Pregnancy |
10.8% |
| Stress Urinary Incontinence |
10.8% |
| Thrombocytopenia |
10.8% |
| Anosmia |
8.1% |
| Mucosal Inflammation |
8.1% |
| Osteonecrosis |
8.1% |
| Stevens-johnson Syndrome |
5.4% |
| Weight Increased |
5.4% |
| Blood Potassium Decreased |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Hepatitis Acute |
2.7% |
| Oesophageal Cancer Metastatic |
2.7% |
| Respiratory Distress |
2.7% |
| Sneezing |
2.7% |
| Spinal Fracture |
2.7% |
| Stasis Dermatitis |
2.7% |
| Syncope |
2.7% |
| Thrombophlebitis |
2.7% |
| Thrombosis |
2.7% |
| Tonic Clonic Movements |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.0% |
| Asthma |
20.1% |
| Product Used For Unknown Indication |
10.8% |
| Breast Cancer |
5.2% |
| Rheumatoid Arthritis |
4.2% |
| Hypertension |
3.0% |
| Bronchitis |
2.2% |
| Multiple Sclerosis |
2.2% |
| Pain |
2.2% |
| Epilepsy |
1.7% |
| Hiv Infection |
1.5% |
| Depression |
1.4% |
| Ill-defined Disorder |
1.3% |
| Bipolar Disorder |
1.2% |
| Emphysema |
1.2% |
| Obesity |
1.1% |
| Osteoporosis |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Breast Cancer Metastatic |
0.9% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
|
| Breast Mass |
8.3% |
| Death |
8.3% |
| Tremor |
7.3% |
| Visual Disturbance |
7.3% |
| Vomiting |
7.3% |
| Left Ventricular Dysfunction |
6.4% |
| Vision Blurred |
5.5% |
| Pneumonia |
4.6% |
| Somnolence |
4.6% |
| Cognitive Disorder |
3.7% |
| Heat Stroke |
3.7% |
| Hypersensitivity |
3.7% |
| Hyponatraemia |
3.7% |
| Laryngeal Oedema |
3.7% |
| Metastases To Central Nervous System |
3.7% |
| Pain |
3.7% |
| Pulmonary Embolism |
3.7% |
| Pulmonary Hypertension |
3.7% |
| Swelling Face |
3.7% |
| Transient Ischaemic Attack |
3.7% |
|
